A Study to Evaluate the Safety and Tolerability of BMS-986408 Alone and in Combination With Nivolumab or Nivolumab and Ipilimumab in Participants With Advanced Solid Tumors
Clinical trial NCT05407675 · COMPLETED
Trial details
- NCT number
- NCT05407675
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-02
- Primary completion
- 2024-08-22
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.